Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_07-cv-03854/USCOURTS-cand-3_07-cv-03854-1/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Personal Injury

---

C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

Richard Sax (State Bar No. 80632)

Richard@rsaxlaw.com

LAW OFFICES OF RICHARD SAX

448 Sebastopol Avenue

Santa Rosa, CA 95401

Telephone: (707) 525-1824

Facsimile: (707) 525-8119

Attorney for Plaintiffs Ryan L. Hobbs and

Michelle Hobbs

Jay R. Henneberry (State Bar No. 135065)

jhenneberry@chadbourne.com

Robin D. Ball (State Bar No. 159698)

rball@chadbourne.com

CHADBOURNE & PARKE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071

Telephone: (213) 892-1000

Facsimile: (213) 622-9865

Attorneys for Purdue Defendants

Douglas C. Emhoff (State Bar No. 151049)

demhoff@venable.com

Jeffrey M. Tanzer (State Bar No. 129437)

jtanzer@venable.com

VENABLE LLP

2049 Century Park East, Suite 2100

Los Angeles, CA 90067

Telephone: (310) 229-9900

Facsimile: (310) 229-9901

Attorneys for Defendant Abbott Laboratories, Inc.

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

RYAN L. HOBBS and MICHELLE

HOBBS,

Plaintiffs,

v.

PURDUE PHARMA COMPANY, et al.,

Defendants.

Case No. C-07-3854-BZ

STIPULATION AND [PROPOSED]

CONSENT PROTECTIVE ORDER OF

CONFIDENTIALITY

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 1 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 2 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

WHEREAS, plaintiff Ryan L. Hobbs and Michelle Hobbs ("Plaintiffs") and

defendants Purdue Pharma L.P. (individually, and as successor-in-interest to The Purdue Pharma

Company and Purdue Pharma Ltd.); Purdue Pharma Inc.; The Purdue Frederick Company Inc.

(d/b/a The Purdue Frederick Company); Purdue Pharmaceuticals L.P.; Pharmaceutical Research

Associates, Inc.; and The P.F. Laboratories, Inc. (collectively, "Purdue"); and Abbott

Laboratories, Inc. (together with Purdue, "Defendants") are conducting discovery in connection

with the above-captioned action;

WHEREAS, Plaintiffs and Defendants desire, by entering into this stipulation, to

preserve the confidentiality of certain information provided in connection with this action;

WHEREAS, Purdue submits concurrently herewith the Declaration of Russell J.

Gasdia in Support of Stipulation and [Proposed] Consent Protective Order of Confidentiality

("Gasdia Declaration"); and

WHEREAS, Plaintiffs do not concede or admit any statements in the Gasdia

Declaration, but consent to entry of this [Proposed] Consent Protective Order of Confidentiality;

THEREFORE, Plaintiffs and Defendants hereby stipulate to entry of the following

Protective Order:

1. This Protective Order shall govern the use and dissemination of all

information, documents or materials designated as Confidential produced within this action or

deemed produced.

2. The term "document," as used in this Protective Order shall have the same

meaning as contemplated by the Federal Rules of Civil Procedure.

3. "Trade Secret" means documents or information not in the public domain that

contain information which is proprietary or competitively sensitive whose disclosure could cause

competitive injury.

4. Any party to this action or other person who produces, supplies, or provides

access to information, documents or other tangible items for use in this action in the course of

discovery (hereinafter the "Designating Party" or the "Producing Party") may designate as

"Confidential" any such material that it reasonably and in good faith believes is (i) a Trade Secret

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 2 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 3 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

or other confidential research, development or commercial information, including but not limited

to sensitive financial data; technical information; proprietary or nonpublic commercial

information; or commercially and/or competitively sensitive information, (ii) material or

information not appropriate for public disclosure because of personal privacy interests ("Sensitive

Personal Information") or contractual rights of third parties (including but not limited to

proprietary information purchased from third parties), (iii) material or information which is

subject to any Protective Order, sealing order or other order or ruling that prevents or limits the

Designating Party from disclosing such document, or (iv) is otherwise protectable under

applicable rules, statutes or common law. If upon review any party reasonably and in good faith

believes that any documents, information or tangible items designated by a Designating Party are

not "Confidential" as defined hereinabove, then the party may challenge such designation under

the procedures set forth below in paragraph 11.

5. Documents, information or other tangible items shall be designated as

Confidential information by marking words that in substance state:

CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER IN HOBBS v.

PURDUE PHARMA COMPANY ET AL., NO. C-07-3854-BZ (N.D. CAL).

Copies of Confidential information shall not obscure this legend or other identifying Bates

numbers.

6. Confidential information shall not be disclosed other than as expressly

authorized in this Order and may be disclosed only to:

a. This Court and its personnel.

b. Counsel of record in this litigation, Counsel listed on Exhibit A (attached

hereto), in-house Counsel for a Defendant, and staff persons employed by such Counsel.

c. Any consultant, investigator or Expert (collectively, "Expert") who is assisting

in the preparation and trial of this litigation provided that, prior to disclosure, Counsel for the

party contemplating disclosure shall determine that disclosure to an Expert of particular

Confidential information is, in that counsel's good faith judgment, necessary to that party's

prosecution or defense of the case. With respect to Experts for the Defendants, only outside

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 3 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 4 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

retained Experts may have access to the Confidential information of a Co-Defendant.

d. A deponent, but only during the course of his or her deposition, or in

preparation thereof.

e. A Court reporter.

f. Plaintiffs, in the presence of their counsel.

g. Defendants, subject to the following condition: unless given permission by the

Designating Party, Defendants may not have access to Confidential documents, materials or

information produced by a Co-Defendant.

h. Fact witnesses or potential fact witnesses, if disclosure to a potential fact

witness of particular Confidential information is, in that counsel's good faith judgment, necessary

to that party's prosecution or defense of the case.

7. If a party wishes to disclose any information designated as Confidential to any

person not described in paragraph 6 of this Order, permission to so disclose must be requested

from the Designating Party in writing. If the Designating Party objects to the proposed

disclosure, no such disclosure shall be made unless this Court, upon application by the party

requesting such permission, orders otherwise.

8. Any person to whom Confidential information may be disclosed pursuant to

paragraphs 6 and 7 hereof (except for this Court and its personnel) shall first be shown and shall

read a copy of this Protective Order and shall agree in writing to be bound by its terms by signing

a copy of Confidentiality Agreement B attached as Exhibit B. Counsel for the party obtaining the

person's signature on the Confidentiality Agreement will retain the original signed agreement. At

the conclusion of the case, counsel will provide to Defendants copies of the signed agreements.

9. Where any Confidential information is included in any papers filed with the

Court, such papers shall be marked in words that in substance state:

CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER IN HOBBS v. PURDUE

PHARMA COMPANY ET AL., NO. C-07-3854-BZ (N.D. CAL).

and placed in a sealed envelope marked with the caption of the case and held under seal in

accordance with the local rules and practices of this Court for such pleadings and documents.

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 4 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 5 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

Inadvertent failure to designate any information pursuant to this Protective Order shall not

constitute a waiver of any otherwise valid claim for protection, so long as such claim is asserted

within thirty (30) days of the discovery of the inadvertent failure. At such time, arrangements

shall be made for return of all copies of the inadvertently misdesignated documents to the

Designating Party and for the submission, where appropriate, of properly labeled copies. If,

during a deposition or within thirty (30) days thereafter, a Designating Party advises the Court

reporter that Confidential Information has been disclosed during a deposition, the entire transcript

shall be treated as confidential for thirty (30) days after receipt of the deposition transcript, within

which time Counsel for the Designating Party shall advise the Court reporter of the pages and

lines on which Confidential information appears. At the conclusion of such thirty (30) day

period, transcript pages and Exhibits containing Confidential information shall continue to be

treated as Confidential under this Order, and shall be designated:

CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER IN HOBBS v. PURDUE

PHARMA COMPANY ET AL., NO. C-07-3854-BZ (N.D. CAL).

before the transcript is distributed. The court reporter shall include on the cover page a clear

indication that portions of the deposition have been designated confidential.

10. A Designating Party may in good faith redact Sensitive Personal Information,

as defined above in Paragraph 4(ii), from any document or material. However, copies of such

documents shall be maintained by the Designating Party without redaction of Sensitive Personal

Information. Counsel for a discovering party and, if necessary, Experts satisfying paragraph 6,

may have access to the unredacted versions of such documents, subject to any applicable federal

regulation, including but not limited to 21 C.F.R. § 20.63 et seq., at the office of the Designating

Party's local counsel, but only for the purpose of ascertaining the appropriateness of any

redactions. If upon review any party reasonably and in good faith believes that any documents,

information or tangible items redacted by a Designating Party pursuant to this paragraph should

not have been redacted, then the party may challenge such redaction by first identifying such

redaction by bates number page and line and then by following the procedures set forth below in

paragraph 11.

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 5 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 6 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

11. If upon review any party reasonably and in good faith believes that any

documents, information or tangible items designated by a Designating Party are not

"Confidential" as defined hereinabove, then the party may challenge such designation by

notifying the Designating Party in writing at any time prior to thirty (30) days before the first

deadline for exhibit lists for any party. The written notice must specifically identify the

challenged documents, information or tangible items, by bates number page where available. The

Designating Party must then seek a protective order from the Court for such documents,

information or tangible items. Failure to file a motion for a protective order within thirty (30)

days from receiving notification of a party's challenge to the designation shall cause such

documents, information or tangible items to be excluded from the provisions of this order.

12. No one may attend, or review the Confidential portions of a deposition, or a

transcript of any deposition, other than persons listed in paragraphs 6 and 7 and counsel for the

deponent (after counsel has read this Protective Order and signed Confidentiality Agreement B).

13. Any presentation of Confidential information to the Court prior to the trial

shall be made only in the presence of persons listed in paragraphs 6 and 7 unless the Court

otherwise orders.

14. Except to the extent expressly authorized in this Protective Order, Confidential

information shall not be used or disclosed for any purpose other than the preparation and/or trial

of this case and/or appeal therefrom. Nothing in this Protective Order shall restrict a Designating

Party's use of its own documents.

15. Any notes, summaries, compilations or copies containing Confidential

information or electronic images or databases containing Confidential information shall be

subject to the terms of this Protective Order to the same extent as the material or information from

which such notes, summaries, compilations, copies, electronic images or databases is made or

derived.

16. In the case of inadvertently produced privileged and/or work product

documents, upon request of the Producing Party, the documents together with all copies thereof

shall be returned to the party claiming privilege and/or work product immunity within seven (7)

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 6 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 7 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

days of receipt of notice of the inadvertent production and any notes made therefrom shall be

destroyed. Inadvertent production of privileged material does not constitute a waiver. A party

returning inadvertently produced documents pursuant to this paragraph does not waive its right to

challenge the privileged and/or work product status of those documents. In support of such a

challenge, a party returning inadvertently produced documents may, at that time, submit a copy of

the returned documents to the Court under seal, to be opened in camera only if the party elects to

challenge the privileged and/or work product status of those documents; if the party returning

inadvertently produced documents fails to file a motion to compel production of these documents

with fourteen (14) days of submitting them to the Court, the documents will be returned to the

Designating Party.

17. This Protective Order does not affect any party's rights to object to discovery

on any grounds other than an objection based solely on the ground that the information sought

contains Trade Secrets or Confidential Information.

18. This Protective Order is without prejudice to the right of any party to seek

modification thereof from the Court and shall remain in effect until such time as it is modified,

amended or set aside by the Court.

19. This Protective Order is not intended to prohibit the use or admissibility of

Confidential information upon trial of this action. Issues involving the protection of Confidential

information during trial will be presented to the Court prior to or during trial as each party deems

appropriate.

20. In the event that additional parties are named in this Action, neither they nor

their Counsel shall have access to Confidential discovery material until executing Confidentiality

Agreement B, and filing the agreement with the Court to reflect that addition of new counsel of

record.

21. Within sixty (60) days after the final disposition of this action, all documents

and materials containing Confidential information (other than exhibits to the official court record)

shall be returned to the Designating Party or, at the sole option and request of the Designating

Party, destroyed at the Designating Party's expense. The attorneys returning documents

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 7 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 8 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

containing Confidential Information may retain their attorney 'work product' and privileged

attorney-client correspondence as may be necessary in their reasonable good judgment to comply

with ethical requirements and/or insurer requirements; provided, however, that this exception

shall not apply to any copies of Confidential documents that are incorporated into or attached to

attorney-client communications or attorney work product. Counsel for any party or third party

receiving confidential information shall make written certification of compliance with this

provision and shall deliver the same to counsel for each Designating Party. If at the time of the

final disposition of this action, any individual counsel of record for Plaintiffs in this action is

currently counsel of record in any other OxyContin®-related products liability litigation

involving Defendants, then the deadline for that particular counsel to fulfill the obligations in this

paragraph shall be sixty (60) days after the final disposition of the final OxyContin®-related

products liability litigation in which he or she is counsel of record; the deadline for all other

individuals possessing documents and materials containing Confidential information pursuant to

this Protective Order shall remain sixty (60) days after the final disposition of this action.

22. Nothing in this Protective Order shall restrict or prohibit a party from seeking

protections in addition to those set forth in this Protective Order for a particular document(s) or

for particular testimony given in this Action.

23. If another court or administrative agency subpoenas or orders production of

Confidential Information that a party has obtained under the terms of this Protective Order, such

party shall, if there are fewer than ten (10) days to comply, within two (2) days of receiving the

subpoena or order, or if more than ten (10) days to comply, at least seven (7) business days prior

to the due date of compliance, notify the Designating Party of the pendency of the subpoena or

order in writing, and shall not produce the Confidential Information until the Designating Party

has had reasonable time to take appropriate steps to protect the material. It shall be the

responsibility of the Designating Party to obtain relief from the subpoena or order prior to the due

date of compliance, and to give the Designating Party an opportunity to obtain such relief, the

party from whom the information is sought shall not make the disclosure before the actual due

date of compliance set forth in the subpoena or order.

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 8 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 9 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

24. The obligations of this Protective Order shall survive the termination of this

Action and shall continue to restrict the disclosure and use of discovery material designated as

Confidential Information by the parties, their counsel, and all who signed a Confidentiality

Agreement. Following termination of this Action, the Court will retain jurisdiction to enforce the

terms of this Protective Order.

Highly Confidential Information

25. A Designating Party may designate as "Highly Confidential" confidential

research, development or commercial information which is so proprietary or competitively

sensitive that there is a reasonable likelihood that its disclosure might cause irreparable

competitive injury, such as product formulas, specifications, recipes and manufacturing

processes; development of new products or technologies; business, financial and marketing plans

having current or future applicability. The designation "Highly Confidential Information" shall

be made by affixing on the document or material containing such information the legend that in

substance states:

HIGHLY CONFIDENTIAL - ACCESS RESTRICTED BY COURT ORDER IN HOBBS v.

PURDUE PHARMA COMPANY ET AL., NO. C-07-3854-BZ (N.D. CAL.).

26. Highly Confidential Information shall not be disclosed other than as expressly

authorized in this Order and may be disclosed only as follows:

a. Highly Confidential Information may be disclosed only to persons who satisfy

the conditions stated in paragraphs 6 and 7, plus these two additional requirements:

i. Any person to whom Highly Confidential information may be

disclosed, except this Court and its personnel, shall first be shown and shall read a

copy of this Protective Order and shall agree in writing to be bound by its terms by

signing a copy of the Confidentiality Agreement C attached as Exhibit C; counsel for

the party obtaining the person's signature on the Confidentiality Agreement will retain

the original signed agreement; and

ii. Highly Confidential information may not be disclosed to any individual

who is currently an officer, director, or employee (as further described in

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 9 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 10 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

Confidentiality Agreement C) of any entity that is engaged in the pharmaceutical

business or the business of supplying pharmaceutical products or ingredients or

machinery used in the manufacture of pharmaceutical products ("Competitor").

Highly Confidential information also may not be disclosed to any individual who is

currently a consultant or agent for any Competitor in areas relating to the design,

formulation, manufacture, sale or marketing of controlled-release pharmaceuticals,

prescription analgesic pharmaceuticals, or any ingredients or machinery used in the

manufacture of controlled-release pharmaceuticals or prescription analgesic

pharmaceuticals.

iii. If the Plaintiffs believe that the restrictions of this Protective Order

relating to disclosure of Highly Confidential information to an Expert inappropriately

prejudices the Plaintiffs with respect to a particular Expert, the parties agree that the

Plaintiffs may move the court for relief from the restrictions of this order upon a

showing of good cause including, for example, the absence of the likelihood of actual

prejudice to the Designating Party. If an Expert has specifically relied upon and

quoted or attached Highly Confidential information to his or her expert report in

another case, this shall create a rebuttable presumption that the Designating Party

would not be prejudiced by allowing such Expert to have access to the same Highly

Confidential information in this action.

b. Except as stated in this paragraph, all other provisions of the Protective Order

that refer to Confidential information shall also apply to Highly Confidential information, except

that references to the "Confidentiality Agreement B" shall be replaced by "Confidentiality

Agreement C" and the designation used with Highly Confidential information shall be that shown

in paragraph 25.

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 10 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 11 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

EXHIBIT A

Richard Sax, LAW OFFICES OF RICHARD SAX

Jay R. Henneberry, Robin D. Ball, Donald I Strauber, CHADBOURNE & PARKE

Douglas C. Emhoff, Jeffrey M. Tanzer, Paul F. Strain, M. King Hill, III, VENABLE LLP

Chilton D. Varner, Robert K. Woo, KING & SPALDING LLP

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 11 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 12 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

EXHIBIT B

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

RYAN L. HOBBS and MICHELLE

HOBBS,

Plaintiffs,

v.

PURDUE PHARMA COMPANY, et al.,

Defendants.

Case No. C-07-3854-BZ

CONFIDENTIALITY AGREEMENT B

STATE OF __________________

COUNTY/PARISH OF ____________________

BEFORE ME, the undersigned authority for the State and County aforesaid, personally came and

appeared: , who, after being duly sworn, did

depose and state the following:

1. I have read and understand the "Protective Order" to which this Confidentiality

Agreement is attached as Exhibit B and I attest to my understanding that access to information

designated "Confidential" may be provided to me and that such access is subject to the terms and

conditions of such Protective Order. I agree to be bound by such terms and conditions. I hereby

submit to the jurisdiction of this Court and to the application of federal law for the purpose of

enforcement of this Confidentiality Agreement and the Protective Order. I have not previously

violated any other confidentiality agreement or protective order.

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 12 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 13 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

2. I shall not use or disclose to others, except in accordance with the Protective

Order, any Confidential information as described or designated in accordance with this

agreement. I understand that the Designating Parties retain all rights to enforce the Protective

Order and all remedies regarding any violations of the same.

__________________________________ __________________________________

Dated Signature

__________________________________

Printed Name

__________________________________

__________________________________

Address

__________________________________

Individual or Entity Represented

Subscribed and sworn to before me on this ____ day of _______________, 20___, by

________________________________, proved to me on the basis of satisfactory evidence to be

the person who appeared before me.

Notary Public

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 13 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 14 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

EXHIBIT C

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

RYAN L. HOBBS and MICHELLE

HOBBS,

Plaintiffs,

v.

PURDUE PHARMA COMPANY, et al.,

Defendants.

Case No. C-07-3854-BZ

CONFIDENTIALITY AGREEMENT C

STATE OF __________________

COUNTY/PARISH OF ____________________

BEFORE ME, the undersigned authority for the State and County aforesaid, personally came and

appeared: , who, after being duly sworn, did

depose and state the following:

1. I have read and understand the "Protective Order" to which this Confidentiality

Agreement is attached as Exhibit C and I attest to my understanding that access to information

designated "Confidential" or "Highly Confidential" may be provided to me and that such access is

subject to the terms and conditions of such Protective Order. I agree to be bound by such terms

and conditions. I hereby submit to the jurisdiction of this Court and to the application of federal

law for the purpose of enforcement of this Confidentiality Agreement and the Protective Order. I

have not previously violated any other confidentiality agreement or protective order.

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 14 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 15 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

2. I am not currently an officer, director, or employee (other than in-house or

outside counsel) of any entity that is engaged in the pharmaceutical business or the business of

supplying pharmaceutical products or ingredients or machinery used in the manufacture of

pharmaceutical products ("Competitor"). I am also not currently a consultant or agent for any

Competitor in areas relating to the design, formulation, manufacture, sale or marketing of

controlled-release pharmaceuticals, prescription analgesic pharmaceuticals, or any ingredients or

machinery used in the manufacture of controlled-release pharmaceuticals or prescription

analgesic pharmaceuticals. Should such an employment opportunity become available to me, I

agree to consult with the Designating Party in an effort to structure the arrangement in a way

which will not pose a material risk of unauthorized use or disclosure of Highly Confidential

Information. As used in this paragraph, a "consultant" of a Competitor is a person who performs

outsourced professional services for a Competitor, but who is not an employee. The term

"consultant" specifically does not include any person who may have received a research grant

from a Competitor, as long as the purpose of the grant is to allow the recipient to conduct research

and to publish that research, and as long as that person is under no obligation to provide

professional advice to the Competitor. The term "consultant" also specifically does not include

any person participating in or conducting clinical trials for a Competitor, as long as that person is

under no obligation to provide professional advice to the Competitor.

/ / /

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 15 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 16 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

3. I shall not use or disclose to others, except in accordance with the Protective

Order, any Confidential or Highly Confidential information as described or designated in

accordance with this agreement. I understand that the Designating Parties retain all rights to

enforce the Protective Order and all remedies regarding any violations of the same.

__________________________________ __________________________________

Dated Signature

__________________________________

Printed Name

__________________________________

__________________________________

Address

__________________________________

Individual or Entity Represented

Subscribed and sworn to before me on this ____ day of _______________, 20___, by

________________________________, proved to me on the basis of satisfactory evidence to be

the person who appeared before me.

Notary Public

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 16 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 17 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

Dated: February __, 2008 LAW OFFICES OF RICHARD SAX

By

Richard Sax

Attorney for Plaintiffs

Ryan L. Hobbs and Michelle Hobbs

Dated: February __, 2008 CHADBOURNE & PARKE LLP

By: /s/ Jay R. Henneberry

Jay R. Henneberry

Robin D. Ball

Attorneys for Defendants

Purdue Pharma L.P. (individually, and as

successor-in-interest to The Purdue Pharma

Company and Purdue Pharma Ltd.);

Purdue Pharma Inc.; The Purdue Frederick

Company Inc. (d/b/a The Purdue Frederick

Company); Purdue Pharmaceuticals L.P.;

Pharmaceutical Research Associates, Inc.;

and The P.F. Laboratories, Inc.

Dated: February __, 2008 VENABLE LLP

By:

Douglas C. Emhoff

Jeffrey M. Tanzer

Attorneys for Defendant

Abbott Laboratories, Inc.

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 17 of 18
C

H

A

D

B

O

U

R

NE & PA

R

KE LLP

350 South Grand Avenue, Suite 3300

Los Angeles, CA 90071 (213) 892-1000

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

- 18 -

STIPULATION AND [PROPOSED] CONSENT PROTECTIVE ORDER OF CONFIDENTIALITY

CASE NO. C-07-3854-BZ

LA1 - 115158.02

[PROPOSED] ORDER

It appearing to the Court that plaintiffs Ryan L. Hobbs and Michelle Hobbs

("Plaintiffs") and defendants Purdue Pharma L.P. (individually, and as successor-in-interest to

The Purdue Pharma Company and Purdue Pharma Ltd.); Purdue Pharma Inc.; The Purdue

Frederick Company Inc. (d/b/a The Purdue Frederick Company); Purdue Pharmaceuticals L.P.;

Pharmaceutical Research Associates, Inc.; The P.F. Laboratories, Inc.; and Abbott Laboratories,

Inc. (collectively "Defendants") have shown good cause for this Protective Order and that

Plaintiffs and Defendants have agreed, pursuant to the Stipulation above,

IT IS HEREBY ORDERED that the foregoing procedures and provisions shall govern

Plaintiffs and Defendants for material/information produced in this action.

IT IS SO ORDERED.

Dated:

UNITED STATES MAGISTRATE JUDGE

February 25, 2008

Nothing in this 

Order exempts the parties from L.R. 79-5.

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORN

I

A

IT IS SO ORDERED

Judge Bernard Zimmerman

Case 3:07-cv-03854-BZ Document 32 Filed 02/25/08 Page 18 of 18